Mineralys Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MLYS | TVTX | ALMS | LYCA | SLDB | ARDX | |
|---|---|---|---|---|---|---|
| Market cap | 1.50B | 5.03B | 847.80M | 1.51B | 699.11M | 849.44M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -7.1 | 9.9 | -2.3 | — | -3.8 | 11.2 |
| Price/book | 2.1 | 222.1 | 1.9 | -3.2 | 2.9 | 4.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −59.67% | +46.53% | +42.23% | −8.00% | +59.80% | −49.08% |
| Today | +6.32% | +6.09% | +0.77% | +4.78% | +3.82% | +8.58% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All MLYS news ›Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026
RADNOR, Pa., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing me... Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference…
Mineralys Therapeutics announces full results from Explore-CKD trial
Mineralys Therapeutics (MLYS) announced that the full results from the Phase 2 Explore-CKD trial of lorundrostat in participants with uncontroll... Mineralys Therapeutics announces full results from Explore-CKD trial Mineralys Therapeutics…
Advance-HTN: Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension
Slide Presentation: Advance-HTN: Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension Submit your research to the journal of the Heart Team.
Mineralys Therapeutics Expands its Board of Directors with the Appointments of Kristine Peterson and Lonnel Coats
RADNOR, Pa., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing me... Mineralys Therapeutics Expands its Board of Directors with the Appointments of Kristine…
New Material Boosts Angiotensin II Test Accuracy
Wollongong-based online news outlet covering Australia and beyond. If you have anything newsworthy - a story, video or picture to share with us, please email us. When two laboratories measure the same biomarker, how can they know that…
Tectonic Therapeutic, Inc. Announces Board and Committees Changes
Tectonic Therapeutic, Inc. announced it has appointed François Nader, M.D., MBA, as an independent director to its Board of Directors, and as a member of the Nominating and Corporate Governance... announced it has appointed François…
Tectonic Therapeutic, Inc. Appoints Jessica Chutter to Board of Directors, Effective June 8, 2026
Tectonic Therapeutic, Inc. announced it has appointed Jessica Chutter to its Board of Directors, effective June 8, 2026. Ms. Chutter brings more than four decades of experience in global healthcare... announced it has appointed Jessica…
Mineralys Therapeutics, Inc. Announces Board Appointments, Effective October 19, 2026
Mineralys Therapeutics, Inc. announced that Kristine Peterson and Lonnel Coats had been appointed to its Board of Directors effective as of October 19, 2026. Ms. Peterson is a biopharmaceutical... announced that Kristine Peterson and…
[Form 3] Mineralys Therapeutics, Inc. Initial Statement of Beneficial Ownership
Mineralys Therapeutics (MLYS) is a clinical-stage biopharma company developing lorundrostat for hypertension, chronic kidney disease, OSA and aldosterone-driven diseases. - [Form 3] Mineralys Therapeutics, Inc. Initial Statement of…
Mineralys Therapeutics (NASDAQ:MLYS) Upgraded at UBS Group
Posted by Kim Johansen on Oct 14th, 2026 UBS Group upgraded shares of Mineralys Therapeutics (NASDAQ:MLYS – Free Report) to a hold rating in a report issued on Sunday,Zacks reports. Read Our Latest Research Report on MLYS Mineralys…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com12
- markets.businessinsider.com7
- stocktitan.net3
- biobuzz.io2
- themarketsdaily.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 27 articles, not a forecast.